Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hahn

Showing results (1011-1020 of 1,074) with videos related to

Pageof 108
Sort By:
Plos Pathogens|June 14, 2012
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escapeKatharine J Bar, Chun-yen Tsao, Shilpa S Iyer, et al.
Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.
The Journal of Clinical Investigation|December 11, 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K P Liu, Natalie Hawkins, Adam J Ritchie, et al.
Nature|January 5, 2018
Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV hostDavid Palesch, Steven E Bosinger, Gregory K Tharp, et al.
Journal of Virology|October 10, 2008
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaGeorgia D Tomaras, Nicole L Yates, Pinghuang Liu, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
Journal of Virology|May 1, 2009
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challengeNancy A Wilson, Brandon F Keele, Jason S Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Nature|June 25, 2016
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionJohannes F Scheid, Joshua A Horwitz, Yotam Bar-On, et al.
Pageof 108

Showing results (1011-1020 of 1,074) with videos related to

Sort By:
Pageof 108
Plos Pathogens|June 14, 2012
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escapeKatharine J Bar, Chun-yen Tsao, Shilpa S Iyer, et al.
Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.
The Journal of Clinical Investigation|December 11, 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K P Liu, Natalie Hawkins, Adam J Ritchie, et al.
Nature|January 5, 2018
Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV hostDavid Palesch, Steven E Bosinger, Gregory K Tharp, et al.
Journal of Virology|October 10, 2008
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaGeorgia D Tomaras, Nicole L Yates, Pinghuang Liu, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
Journal of Virology|May 1, 2009
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challengeNancy A Wilson, Brandon F Keele, Jason S Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.
Nature Medicine|September 8, 2020
Recommendations for measuring HIV reservoir size in cure-directed clinical trialsMohamed Abdel-Mohsen, Douglas Richman, Robert F Siliciano, et al.
Nature|June 25, 2016
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionJohannes F Scheid, Joshua A Horwitz, Yotam Bar-On, et al.
Pageof 108